• Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer.
    • Batalini F, Xiong N, Tayob N, Polak M, Eismann J, Cantley LC, Shapiro GI, Adalsteinsson V, Winer EP, Konstantinopoulos PA, D'Andrea AD, Swisher EM, Matulonis UA, Wulf GM. Mayer EL.
    • Clin Cancer Res. 2022 Feb 11:clincanres.3045.2021. doi: 10.1158/1078-0432.CCR-21-3045. Epub ahead of print.